Business Description
DocCheck AG
ISIN : DE000A1A6WE6
Share Class Description:
XTER:AJ91: Namen-AktTotal Employee Number:
414Compare
Compare
Traded in other countries / regions
AJ91.Germany IPO Date
2000-04-17Description
DocCheck AG operates in the healthcare sector. Along with its subsidiaries, it operates across the following segments: DocCheck Agency, DocCheck, and DocCheck Shop. Maximum revenue is derived from the DocCheck Agency segment, which develops and implements communication concepts for the healthcare and B2B markets using both new and traditional media. The DocCheck Shop segment sells medical supplies and medical technology, mainly via mail order, to various medical professional groups, and the DocCheck segment represents the Group's access and portal business, which involves verifying and granting access rights and providing research and communication services with and for members of medical professional groups. Geographically, the Group generates maximum revenue from Germany.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 4.45 | |||||
Equity-to-Asset | 0.75 | |||||
Debt-to-Equity | 0.1 | |||||
Debt-to-EBITDA | 0.36 | |||||
Interest Coverage | 21.3 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 5.05 | |||||
Beneish M-Score | -2.3 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -3.2 | |||||
3-Year EBITDA Growth Rate | -4.9 | |||||
3-Year EPS without NRI Growth Rate | -2.3 | |||||
3-Year Book Growth Rate | 2.3 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 42.48 | |||||
9-Day RSI | 44.59 | |||||
14-Day RSI | 43.18 | |||||
3-1 Month Momentum % | -10.85 | |||||
6-1 Month Momentum % | -8.73 | |||||
12-1 Month Momentum % | -4.96 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.18 | |||||
Quick Ratio | 2.86 | |||||
Cash Ratio | 1.74 | |||||
Days Inventory | 68.89 | |||||
Days Sales Outstanding | 47.32 | |||||
Days Payable | 52.27 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 9.09 | |||||
Dividend Payout Ratio | 0.76 | |||||
3-Year Dividend Growth Rate | -9.1 | |||||
Forward Dividend Yield % | 9.09 | |||||
5-Year Yield-on-Cost % | 27.06 | |||||
3-Year Average Share Buyback Ratio | -0.3 | |||||
Shareholder Yield % | 10.16 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 67.45 | |||||
Operating Margin % | 15.87 | |||||
Net Margin % | 9.64 | |||||
EBITDA Margin % | 20.93 | |||||
FCF Margin % | 4.04 | |||||
OCF Margin % | 10.81 | |||||
ROE % | 13.29 | |||||
ROA % | 9.54 | |||||
ROIC % | 18.48 | |||||
3-Year ROIIC % | 9.43 | |||||
ROC (Joel Greenblatt) % | 57.3 | |||||
ROCE % | 19.87 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 10.76 | |||||
PE Ratio without NRI | 11.48 | |||||
Shiller PE Ratio | 9.65 | |||||
Price-to-Owner-Earnings | 18.09 | |||||
PS Ratio | 1.04 | |||||
PB Ratio | 1.38 | |||||
Price-to-Tangible-Book | 1.37 | |||||
Price-to-Free-Cash-Flow | 25.62 | |||||
Price-to-Operating-Cash-Flow | 9.59 | |||||
EV-to-EBIT | 4.74 | |||||
EV-to-EBITDA | 3.59 | |||||
EV-to-Revenue | 0.75 | |||||
EV-to-FCF | 18.53 | |||||
Price-to-GF-Value | 1.16 | |||||
Price-to-Projected-FCF | 0.76 | |||||
Price-to-Median-PS-Value | 0.7 | |||||
Price-to-Graham-Number | 0.82 | |||||
| Price-to-Net-Current-Asset-Value | 2.81 | |||||
| Price-to-Net-Cash | 12.5 | |||||
Earnings Yield (Greenblatt) % | 21.11 | |||||
FCF Yield % | 4.01 | |||||
Forward Rate of Return (Yacktman) % | -2.11 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
DocCheck AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 55.315 | ||
| EPS (TTM) (€) | 1.05 | ||
| Beta | 0.7731 | ||
| 3-Year Sharpe Ratio | 0.11 | ||
| 3-Year Sortino Ratio | 0.17 | ||
| Volatility % | 35.6 | ||
| 14-Day RSI | 43.18 | ||
| 14-Day ATR (€) | 0.202881 | ||
| 20-Day SMA (€) | 11.07 | ||
| 12-1 Month Momentum % | -4.96 | ||
| 52-Week Range (€) | 10.6 - 15.9 | ||
| Shares Outstanding (Mil) | 5.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
DocCheck AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
DocCheck AG Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| EUR 1.000000 Cash Dividend | 2026-05-29 | 13.60 (+0.74%) | ||
| EUR 0.750000 Cash Dividend | 2025-05-29 | 12.10 (-0.82%) |
Show
Entries
DocCheck AG Frequently Asked Questions
What is DocCheck AG(XTER:AJ91)'s stock price today?
The current price of XTER:AJ91 is €11.00. The 52 week high of XTER:AJ91 is €15.90 and 52 week low is €10.60.
When is next earnings date of DocCheck AG(XTER:AJ91)?
The next earnings date of DocCheck AG(XTER:AJ91) is .
Does DocCheck AG(XTER:AJ91) pay dividends? If so, how much?
The Dividend Yield %  of DocCheck AG(XTER:AJ91) is 9.09% (As of Today), Highest Dividend Payout Ratio of DocCheck AG(XTER:AJ91) was 1.9. The lowest was 0.06. And the median was 0.76. The  Forward Dividend Yield % of DocCheck AG(XTER:AJ91) is 9.09%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on DocCheck AG
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers